- Ashhar Ali, DO: Interest in Headache
- Helena Bulka, DO: Interest in Multiple sclerosis and Neuroimmunology.
- Michael Chopp, PhD: Dr. Michael Chopp is Vice Chairman for Research of the Department of Neurology, Scientific Director of the Henry Ford Neuroscience Institute, and is the Zoltan J. Kovacs Chair in Neuroscience Research. His research has primarily focused on: 1) cellular and molecular biology of ischemic cell injury, 2) the pathophysiology of stroke, traumatic brain injury, peripheral neuropathy, multiple sclerosis, and glioma, 3) combination thrombolytic and neuro and vascular protective therapies for stroke, 4) mechanisms of neuroprotection, 5) cell-based and pharmacological neurorestorative therapies for stroke, traumatic brain restorative therapies for stroke, traumatic brain injury and neurodegenerative disease, 6) molecular and cellular mechanisms underlying neurogenesis and angio-genesis and the induction of brain plasticity leading to functional and behavioral recovery after neural injury, 7) treatment of glioma and breast cancer, 8) magnetic resonance imaging, and much more.
- Mirela Cerghet, MD, PhD: Interest in Multiple sclerosis and Neuroimmunology.
- Ahmad Riad Ramadan, MD, Neuro-Critical Care Fellowship Director
- Anza Memon, MD: "I have passion for clinical research in the field of multiple sclerosis and neuroimmunology. MS is a growing field with lots of opportunities for basic sciences and clinical research. I would love to take this opportunity to enhance my passion in this field and inspire our resident and fellows to follow the same path.”
- Neepa Patel, MD: Interest in Movement disorders, Clinical trials.
- Ahmad Riad Ramadan, MD: Interests are ischemic strokes, hemorrhagic strokes, gut microbiome, neuroinflammation.
- James Synder, DO: “Dr. Snyder's research is anchored in neuro-oncology including clinical research, as well as, translational efforts through participation in a radiomics research group and the Hermelin Brain Tumor Center 'Omics' laboratory which focuses on epigenetics and bioinformatics.”